Evidence map›Paper›PMID 34641408›Full record

ArticleMolecules (Basel, Switzerland)2021

Hybrid Multivalent Jack Bean α-Mannosidase Inhibitors: The First Example of Gold Nanoparticles Decorated with Deoxynojirimycin Inhitopes.

Costanza Vanni, Anne Bodlenner, Marco Marradi, Jérémy P Schneider, Maria de Los Angeles Ramirez, Sergio Moya, Andrea Goti, Francesca Cardona, Philippe Compain, Camilla Matassini

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Women in Bioorganic Chemistry.Molecules (Basel, Switzerland) · 2022
    Article
  5. Review
  6. 3,4,5-Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers.Chembiochem : a European journal of chemical biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Costanza VanniDipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.
Anne BodlennerLaboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg | University of Haute-Alsace | CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67000 Strasbourg, France.ORCID 0000-0001-5403-7923
Marco MarradiDipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID 0000-0003-0831-6942
Jérémy P SchneiderLaboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg | University of Haute-Alsace | CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67000 Strasbourg, France.
Maria de Los Angeles RamirezSoft Matter Nanotechnology Lab, CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Gipuzkoa, Spain.
Sergio MoyaSoft Matter Nanotechnology Lab, CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 Donostia-San Sebastián, Gipuzkoa, Spain.
Andrea GotiDipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-1081-533X
Francesca CardonaDipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-6766-4624
Philippe CompainLaboratoire d'Innovation Moléculaire et Applications (LIMA), University of Strasbourg | University of Haute-Alsace | CNRS (UMR 7042), Equipe de Synthèse Organique et Molécules Bioactives (SYBIO), ECPM, 25 Rue Becquerel, 67000 Strasbourg, France.
Camilla MatassiniDipartimento di Chimica "Ugo Schiff", Università di Firenze, Via della Lastruccia 3-13, 50019 Sesto Fiorentino, Italy.ORCID 0000-0002-8336-383X

Funding

CNRS UMR 7509MIUR-Italy Progetto Dipartimenti di Eccellenza 2018-2022, allocated to the Department of Chemistry "Ugo Schiff"Università di Firenze and Regione Toscana (Bando Salute 2018) Late onset Lysosomal Storage Disorders (LSDs) in the differential diagnosis of neurodegenerative diseases: development of new diagnostic procedures and focus on potential pharma-cological chaperones (PCs), Acronym: LysolateUniversity of Strasbourg and the Fondation pour la Recherche en Chimie icFRC Strasbourg
6 · The paper itself

Abstract

Among carbohydrate-processing enzymes, Jack bean α-mannosidase (JBα-man) is the glycosidase with the best responsiveness to the multivalent presentation of iminosugar inhitopes. We report, in this work, the preparation of water dispersible gold nanoparticles simultaneously coated with the iminosugar deoxynojirimycin (DNJ) inhitope and simple monosaccharides (β-d-gluco- or α-d-mannosides). The display of DNJ at the gold surface has been modulated (i) by using an amphiphilic linker longer than the aliphatic chain used for the monosaccharides and (ii) by presenting the inhitope, not only in monomeric form, but also in a trimeric fashion through combination of a dendron approach with glyconanotechnology. The latter strategy resulted in a strong enhancement of the inhibitory activity towards JBα-man, with a

Indexed as

1-Deoxynojirimycinalpha-MannosidaseCanavaliaEnzyme InhibitorsGoldMetal Nanoparticles1-Deoxynojirimycinalpha-MannosidaseEnzyme InhibitorsGoldenzyme inhibitiongold nanoparticlesiminosugarsJack bean α-mannosidasemultivalency

Identifiers

PMID34641408
PMCPMC8512634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.